SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000891293-18-000048
Filing Date
2018-03-23
Accepted
2018-03-23 17:02:52
Documents
2
Period of Report
2018-03-23
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cti_-x8xkxrexarxbylawsxmar.htm 8-K 39641
2 EXHIBIT 3.1 cti-amendedandrestatedbyla.htm EX-3.1 131977
  Complete submission text file 0000891293-18-000048.txt   172868
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-28386 | Film No.: 18710843
SIC: 2834 Pharmaceutical Preparations